| Dr Barbara Ann Blankenship, MD | |
|
55 W Tietan St, Walla Walla, WA 99362-4445 | |
| (509) 525-3720 | |
| (509) 525-3720 |
| Full Name | Dr Barbara Ann Blankenship |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 29 Years |
| Location | 55 W Tietan St, Walla Walla, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356305262 | NPI | - | NPPES |
| 8256976 | Medicaid | WA | |
| 171827 | Other | WA | L&I |
| 1008358 | Medicaid | WA | |
| 1356305262 | Medicaid | ID | |
| 324988 | Other | WA | LNI PROVIDER ID |
| 324984 | Other | WA | LNI PROVIDER ID |
| 324986 | Other | WA | LNI PROVIDER ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 12301 (Idaho) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | MD00037722 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lourdes Medical Center | Pasco, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Privia Medical Group Washington Pllc | 2264320837 | 51 |
News Archive
COVID-19 healthcare workers will be psychologically impacted by their work during the pandemic and will require psychological support from multiple levels in their organisations, according to a review by researchers from Queen Mary University of London, London's Air Ambulance and Barts Health NHS Trust, and a London-based A&E doctor.
Protalix BioTherapeutics, Inc. announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers.
Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).
The incidence of advanced breast cancer diagnosis among black women remained 30 percent to 90 percent higher compared to white women between 1992 and 2004, according to new findings by researchers at Fred Hutchinson Cancer Research Center. In addition, the disparity in the incidence of advance colorectal cancer actually widened over this time period as rates fell among whites but increased slightly among blacks.
A large clinical trial called INTERACT, launched in China this month, will determine the effects of early intensive blood pressure lowering on death and disability in stroke patients.
› Verified 6 days ago
| Entity Name | Privia Medical Group Washington Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780658419 PECOS PAC ID: 2264320837 Enrollment ID: O20040309000126 |
News Archive
COVID-19 healthcare workers will be psychologically impacted by their work during the pandemic and will require psychological support from multiple levels in their organisations, according to a review by researchers from Queen Mary University of London, London's Air Ambulance and Barts Health NHS Trust, and a London-based A&E doctor.
Protalix BioTherapeutics, Inc. announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers.
Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).
The incidence of advanced breast cancer diagnosis among black women remained 30 percent to 90 percent higher compared to white women between 1992 and 2004, according to new findings by researchers at Fred Hutchinson Cancer Research Center. In addition, the disparity in the incidence of advance colorectal cancer actually widened over this time period as rates fell among whites but increased slightly among blacks.
A large clinical trial called INTERACT, launched in China this month, will determine the effects of early intensive blood pressure lowering on death and disability in stroke patients.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Barbara Ann Blankenship, MD 55 W Tietan St, Walla Walla, WA 99362-4498 Ph: (509) 525-3720 | Dr Barbara Ann Blankenship, MD 55 W Tietan St, Walla Walla, WA 99362-4445 Ph: (509) 525-3720 |
News Archive
COVID-19 healthcare workers will be psychologically impacted by their work during the pandemic and will require psychological support from multiple levels in their organisations, according to a review by researchers from Queen Mary University of London, London's Air Ambulance and Barts Health NHS Trust, and a London-based A&E doctor.
Protalix BioTherapeutics, Inc. announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers.
Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).
The incidence of advanced breast cancer diagnosis among black women remained 30 percent to 90 percent higher compared to white women between 1992 and 2004, according to new findings by researchers at Fred Hutchinson Cancer Research Center. In addition, the disparity in the incidence of advance colorectal cancer actually widened over this time period as rates fell among whites but increased slightly among blacks.
A large clinical trial called INTERACT, launched in China this month, will determine the effects of early intensive blood pressure lowering on death and disability in stroke patients.
› Verified 6 days ago
Dr. Spencer N Ashton, M.D Radiology Medicare: Accepting Medicare Assignments Practice Location: 401 W Poplar St, Radiation Oncology, Walla Walla, WA 99362 Phone: 509-522-5700 Fax: 509-522-5515 | |
Amit Verma, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 77 Wainwright Dr, Walla Walla, WA 99362 Phone: 509-525-5200 | |
Dr. Allan F Avbel, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 306 Craig St, Walla Walla, WA 99362 Phone: 509-522-1951 Fax: 509-522-1951 | |
Robert E Morris, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 3539 Mill Creek Rd, Walla Walla, WA 99362 Phone: 509-527-3466 | |
Marc Brian Bruce, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 401 W Poplar St, Radiology, Walla Walla, WA 99362 Phone: 509-522-5790 Fax: 509-522-5887 | |
Dr. Joanne M Schmitz, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 55 W Tietan St, Walla Walla, WA 99362 Phone: 509-525-3720 Fax: 509-522-1571 |